AstraZeneca on Saturday said it had restarted its trial in Britain after regulators completed their review of a serious side effect in one trial participant there.from Moneycontrol Latest News https://ift.tt/2Ftj20w
AstraZeneca on Saturday said it had restarted its trial in Britain after regulators completed their review of a serious side effect in one trial participant there.
Post a Comment
Post a Comment
please do not enter spam link in the comment box